Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
Posted: 20 July 2021 | ADARE Pharma Solutions | No comments yet
Using a proprietary Stratµm TM technology, we have created 50 µm capsules with an aqueous core and thin PLA shell.
The microcapsules have implications for encapsulating water-soluble molecules such as peptides and proteins, which can be released with a discrete pulse, or slow ramp in release rate. This process demonstrated that the Stratµm technology could be used to encapsulate aqueous-based high-viscosity solutions containing biological molecules.
Related content from this organisation
- EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions
- Maintaining EU MDR certification: a spotlight on post‑market clinical follow-up
- Formulation, Development & Delivery In-Depth Focus 2021
- Scientific briefing: Formulation-Monodisperse CR quetiapine microspheres
- Scientific briefing: Formulation of aqueous core poly (lactic acid) microcapsules
Related topics
Analytical techniques, Biopharmaceuticals, Excipients, Formulation, Good Manufacturing Practice (GMP), Ingredients, Manufacturing, Research & Development (R&D)